← European Medicine Shortage Tracker · all medicines

Tenofovir disoproxil shortage — availability across Europe

Tenofovir disoproxil currently has availability issues reported in 2 European registers: Italy, Sweden.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Shortage  ATC — · also listed as: TENOFOVIR DISOPROXIL · tenofovirdisoproxilfumarat · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 2 of the 10 tracked registers list current availability issues for Tenofovir disoproxil, covering 2 affected product presentations. Where agencies state a cause, commercial decisions or discontinuation lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-09-30; the earliest is 2026-09-30. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇮🇹 ItalyShortage
STRIBILD
2026-10-30Cessata commercializzazione definitiva
Alternatives: AIFA: an alternative treatment is available (ask your doctor).
register ↗
🇸🇪 SwedenShortage
Tenofovir disoproxil Accordpharma 245 mg Filmdragerad tablett
2026-07-092026-09-30
Alternatives: Alternative(s) available — see the national register.
register ↗

Full report history (2 register entries)

Every individual register entry for Tenofovir disoproxil in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITSTRIBILDShortage2026-10-30Cessata commercializzazione definitiva
🇸🇪 SETenofovir disoproxil Accordpharma 245 mg Filmdragerad tablettShortage2026-07-092026-09-30

Frequently asked

Is Tenofovir disoproxil currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Tenofovir disoproxil shortage expected to end?

Agency prognoses on file range from 2026-09-30 to 2026-09-30. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Tenofovir disoproxil?

2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Tenofovir disoproxil availability data come from?

Directly from the official medicines-agency registers that list Tenofovir disoproxil: AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Tenofovir disoproxil — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/tenofovir-disoproxil/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Tenofovir disoproxil availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/tenofovir-disoproxil/">Tenofovir disoproxil shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Tenofovir disoproxil: availability status across 2 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.